Drug Discovery Outsourcing Market
Drug Discovery Outsourcing Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033 A recent market study published by FMI on Drug Discovery Outsourcing offers a global in... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryDrug Discovery Outsourcing Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033A recent market study published by FMI on Drug Discovery Outsourcing offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision. Market Segmentation By Workflow: • Target Identification & Screening • Target Validation & Functional Informatics • Lead Identification & Candidate Optimization • Preclinical Development • Other Associated Workflow By Therapeutics Area: • Respiratory system • Pain and Anesthesia • Oncology • Ophthalmology • Hematology • Cardiovascular • Endocrine • Gastrointestinal • Immunomodulation • Anti-infective • Central Nervous System • Dermatology • Genitourinary System By Drug Type: • Small Molecules • Large Molecules (Biopharmaceuticals) By Service Type: • Chemistry Services • Biology Services By End-user: • Pharmaceutical & Biotechnology companies • Academic Institutes • Others By Regions: • North America • Europe • Japan • Asia Pacific Excluding Japan • Latin America • MEA Report Chapters Executive Summary The executive summary of the Drug Discovery Outsourcing Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System. Chapter 01 - Market Overview Readers can find the detailed segmentation and definition of the Drug Discovery Outsourcing Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Drug Discovery Outsourcing Market report. Chapter 02 - Market Background This chapter includes detailed analysis of the By Workflow processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market. Chapter 03 - Global Drug Discovery Outsourcing Market Demand Analysis 2018-2022 and Forecast, 2023-2033 The chapter include historical market value (US$ 3.50 billion) analysis (2018-2022) and current and future market value (US$ 3.75 billion) and volume (7.2%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation. Chapter 04 - Global Drug Discovery Outsourcing Market - Pricing Analysis Based on By Workflow, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing. Chapter 05 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Workflow Based on By Workflow, Drug Discovery Outsourcing Market is segmented into Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Workflow. Chapter 06 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Therapeutics Area Based on By Therapeutics Area, Drug Discovery Outsourcing Market is segmented into Respiratory system, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-infective, Central Nervous System, Dermatology, Genitourinary System. This section also offers market attractiveness analysis based on By Therapeutics Area. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Therapeutics Area. Chapter 07 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type Based on By Drug Type, Drug Discovery Outsourcing Market is segmented into Small Molecules, Large Molecules (Biopharmaceuticals). This section also offers market attractiveness analysis based on By Drug Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug Type. Chapter 08 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Service Type Based on By Service Type, Drug Discovery Outsourcing Market is segmented into Chemistry Services, Biology Services. This section also offers market attractiveness analysis based on By Service Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Service Type. Chapter 09 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By End-user Based on By End-user, Drug Discovery Outsourcing Market is segmented into Pharmaceutical & Biotechnology companies, Academic Institutes, Others. This section also offers market attractiveness analysis based on By End-user. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-user. Chapter 10 - Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Regions Based on By Regions, Drug Discovery Outsourcing Market is segmented into North America, Latin America, Europe, Japan, Asia Pacific Excluding Japan and MEA. This section also offers market attractiveness analysis based on By Regions. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Regions. Chapter 11 - North America Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region. Chapter 12 - Latin America Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the Latin America region. Chapter 13 - Europe Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market. Chapter 14 - East Asia Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market. Chapter 15 - South Asia Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market. Chapter 16 - Middle East and Africa Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market. Chapter 17 - Key Countries Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033 This chapter offers insights into how the Drug Discovery Outsourcing Market is expected to grow in major countries globally. Chapter 18 - Market Structure Analysis- Global Assessment This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix. Chapter 19 - Competition Deep Dive (Tentative List) This chapter includes company overview, By Workflow portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Albany Molecular Research Inc., EVOTEC, Laboratory Corporation of America Holdings, GenScript, Pharmaceutical Product Development, LLC, Charles River, WuXi AppTec, Merck & Co., Inc., Thermo Fisher Scientific Inc., Dalton Pharma Services, Oncodesign, Jubilant Biosys, DiscoverX Corp., QIAGEN, Eurofins SE, Syngene International Limited, Dr. Reddy Laboratories Ltd., Pharmaron Beijing Co., Ltd., TCG Lifesciences Pvt Ltd., Domainex Ltd. Chapter 20 - Assumptions and Acronyms This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report. Chapter 21 - Research Methodology This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Drug Discovery Outsourcing Market. Table of Contents1. Executive Summary | Drug Discovery Outsourcing Market1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Workflow, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Workflow, 2023 to 2033 5.3.1. Target Identification & Screening 5.3.2. Target Validation & Functional Informatics 5.3.3. Lead Identification & Candidate Optimization 5.3.4. Preclinical Development 5.3.5. Other Associated Workflow 5.4. Y-o-Y Growth Trend Analysis By Workflow, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Workflow, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics Area 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Therapeutics Area, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapeutics Area, 2023 to 2033 6.3.1. Respiratory system 6.3.2. Pain and Anaesthesia 6.3.3. Oncology 6.3.4. Ophthalmology 6.3.5. Haematology 6.3.6. Cardiovascular 6.3.7. Endocrine 6.3.8. Gastrointestinal 6.3.9. Immunomodulation 6.3.10. Dermatology 6.3.11. Central Nervous System 6.3.12. Genitourinary System 6.4. Y-o-Y Growth Trend Analysis By Therapeutics Area, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Therapeutics Area, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Drug Type, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Type, 2023 to 2033 7.3.1. Small Molecules 7.3.2. Large Molecules 7.4. Y-o-Y Growth Trend Analysis By Drug Type, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Drug Type, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Pharmaceutical and Biotechnology companies 8.3.2. Academic Institutes 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Workflow 10.2.3. By Therapeutics Area 10.2.4. By Drug Type 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Workflow 10.3.3. By Therapeutics Area 10.3.4. By Drug Type 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Workflow 11.2.3. By Therapeutics Area 11.2.4. By Drug Type 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Workflow 11.3.3. By Therapeutics Area 11.3.4. By Drug Type 11.3.5. By End User 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Workflow 12.2.3. By Therapeutics Area 12.2.4. By Drug Type 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Workflow 12.3.3. By Therapeutics Area 12.3.4. By Drug Type 12.3.5. By End User 12.4. Key Takeaways 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Workflow 13.2.3. By Therapeutics Area 13.2.4. By Drug Type 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Workflow 13.3.3. By Therapeutics Area 13.3.4. By Drug Type 13.3.5. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Workflow 14.2.3. By Therapeutics Area 14.2.4. By Drug Type 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Workflow 14.3.3. By Therapeutics Area 14.3.4. By Drug Type 14.3.5. By End User 14.4. Key Takeaways 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Workflow 15.2.3. By Therapeutics Area 15.2.4. By Drug Type 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Workflow 15.3.3. By Therapeutics Area 15.3.4. By Drug Type 15.3.5. By End User 15.4. Key Takeaways 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Workflow 16.2.3. By Therapeutics Area 16.2.4. By Drug Type 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Workflow 16.3.3. By Therapeutics Area 16.3.4. By Drug Type 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Workflow 17.1.2.2. By Therapeutics Area 17.1.2.3. By Drug Type 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Workflow 17.2.2.2. By Therapeutics Area 17.2.2.3. By Drug Type 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Workflow 17.3.2.2. By Therapeutics Area 17.3.2.3. By Drug Type 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Workflow 17.4.2.2. By Therapeutics Area 17.4.2.3. By Drug Type 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Workflow 17.5.2.2. By Therapeutics Area 17.5.2.3. By Drug Type 17.5.2.4. By End User 17.6. United kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Workflow 17.6.2.2. By Therapeutics Area 17.6.2.3. By Drug Type 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Workflow 17.7.2.2. By Therapeutics Area 17.7.2.3. By Drug Type 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Workflow 17.8.2.2. By Therapeutics Area 17.8.2.3. By Drug Type 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Workflow 17.9.2.2. By Therapeutics Area 17.9.2.3. By Drug Type 17.9.2.4. By End User 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Workflow 17.10.2.2. By Therapeutics Area 17.10.2.3. By Drug Type 17.10.2.4. By End User 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Workflow 17.11.2.2. By Therapeutics Area 17.11.2.3. By Drug Type 17.11.2.4. By End User 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Workflow 17.12.2.2. By Therapeutics Area 17.12.2.3. By Drug Type 17.12.2.4. By End User 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Workflow 17.13.2.2. By Therapeutics Area 17.13.2.3. By Drug Type 17.13.2.4. By End User 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Workflow 17.14.2.2. By Therapeutics Area 17.14.2.3. By Drug Type 17.14.2.4. By End User 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Workflow 17.15.2.2. By Therapeutics Area 17.15.2.3. By Drug Type 17.15.2.4. By End User 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Workflow 17.16.2.2. By Therapeutics Area 17.16.2.3. By Drug Type 17.16.2.4. By End User 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Workflow 17.17.2.2. By Therapeutics Area 17.17.2.3. By Drug Type 17.17.2.4. By End User 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Workflow 17.18.2.2. By Therapeutics Area 17.18.2.3. By Drug Type 17.18.2.4. By End User 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Workflow 17.19.2.2. By Therapeutics Area 17.19.2.3. By Drug Type 17.19.2.4. By End User 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Workflow 17.20.2.2. By Therapeutics Area 17.20.2.3. By Drug Type 17.20.2.4. By End User 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Workflow 17.21.2.2. By Therapeutics Area 17.21.2.3. By Drug Type 17.21.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Workflow 18.3.3. By Therapeutics Area 18.3.4. By Drug Type 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Albany Molecular Research Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. EVOTEC 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Laboratory Corporation of America Holdings 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. GenScript 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Pharmaceutical Product Development, LLC 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Merck & Co., Inc. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Thermo Fisher Scientific Inc. 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Dalton Pharma Services 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Dr. Reddy Laboratories Ltd. 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Pharmaron Beijing Co., Ltd. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.11. TCG Lifesciences Pvt Ltd. 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.12. Domainex Ltd. 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.13. Eurofins SE 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 19.1.14. Syngene International Limited 19.1.14.1. Overview 19.1.14.2. Product Portfolio 19.1.14.3. Profitability by Market Segments 19.1.14.4. Sales Footprint 19.1.14.5. Strategy Overview 19.1.14.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Future Market Insights社の医療・製薬・メディカルデバイス分野での最新刊レポート本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問Future Market Insights社はどのような調査会社ですか?Future Market Insights(FMI)は世界の広範な地域および産業を対象にした調査レポートを出版しています。 弊社ウェブサイトに掲載のないタイトルも全てお取り扱い可能ですので... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/05 10:26 151.38 円 159.59 円 194.97 円 |